Professors

Medicine & Life Sciences

1. Percutaneous Coronary Intervention 100%
2. Atrial Fibrillation 88%
3. Myocardial Infarction 55%
4. Stroke 52%
5. Atherosclerosis 49%
6. Thrombosis 45%
7. Mitral Valve 45%
8. Transcatheter Aortic Valve Replacement 42%
9. Warfarin 40%
10. Mortality 39%
11. Acute Coronary Syndrome 38%
12. Stents 38%
13. Therapeutics 36%
14. Hemorrhage 36%
15. Coronary Artery Disease 35%
16. Atherosclerotic Plaques 35%
17. Rivaroxaban 33%
18. Heart Failure 32%
19. Registries 32%
20. Blood Platelets 31%
21. Drug-Eluting Stents 30%
22. Aspirin 30%
23. Cardiovascular Diseases 30%
24. Aortic Valve 28%
25. Coronary Artery Bypass 27%
26. Confidence Intervals 26%
27. Mitral Valve Insufficiency 26%
28. Coronary Vessels 26%
29. Anticoagulants 23%
30. Magnetic Resonance Spectroscopy 23%
31. Magnetic Resonance Imaging 22%
32. Coronary Atherectomy 21%
33. Safety 20%
34. Blood Vessels 19%
35. Vitamin K 18%
36. Lipids 18%
37. Aortic Valve Stenosis 18%
38. Unstable Angina 18%
39. Coronary Disease 18%
40. Swine 18%
41. Equipment and Supplies 17%
42. Incidence 17%
43. Echocardiography 16%
44. Clopidogrel 16%
45. Transplants 16%
46. ST Elevation Myocardial Infarction 16%
47. Embolism 16%
48. Heart-Assist Devices 16%
49. Thromboembolism 15%
50. Pulmonary Hypertension 15%
51. Diabetes Mellitus 14%
52. Thoracic Surgery 14%
53. Arteries 14%
54. Cardiology 14%
55. Heart 14%
56. Clinical Trials 14%
57. Atherectomy 13%
58. Cardiac Arrhythmias 13%
59. Coronavirus 13%
60. Ticagrelor 13%
61. Randomized Controlled Trials 13%
62. Hydroxymethylglutaryl-CoA Reductase Inhibitors 13%
63. Rupture 13%
64. Angioplasty 13%
65. Inflammation 12%
66. Platelet Aggregation Inhibitors 12%
67. Survival 12%
68. Heparin 12%
69. Secondary Prevention 12%
70. Pathologic Constriction 12%
71. Infarction 12%
72. Odds Ratio 11%
73. Population 11%
74. Hypertension 11%
75. Cardiomyopathies 11%
76. Guidelines 11%
77. Stroke Volume 10%
78. Thrombin 10%
79. Hospitalization 10%
80. Macrophages 10%
81. Implantable Defibrillators 10%
82. Hemodynamics 10%
83. Morbidity 10%
84. Sarcoidosis 10%
85. Meta-Analysis 10%
86. Chronic Renal Insufficiency 10%
87. Aorta 10%
88. Everolimus 10%
89. Factor Xa 9%
90. Balloon Angioplasty 9%
91. Coronary Angiography 9%
92. Dabigatran 9%
93. Fluorodeoxyglucose F18 9%
94. Angiography 9%
95. Positron-Emission Tomography 9%
96. Placebos 9%
97. Health 9%
98. Heart Valves 9%
99. Reperfusion 9%
100. Cardiogenic Shock 8%